Free Trial
OTCMKTS:MMEDF

Mind Medicine (MindMed) (MMEDF) Stock Price, News & Analysis

Mind Medicine (MindMed) logo
$6.11 +0.31 (+5.34%)
As of 04/23/2025

About Mind Medicine (MindMed) Stock (OTCMKTS:MMEDF)

Key Stats

Today's Range
$6.00
$6.33
50-Day Range
$4.89
$9.89
52-Week Range
$0.29
$5.07
Volume
976,240 shs
Average Volume
3.38 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Receive MMEDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Medicine (MindMed) and its competitors with MarketBeat's FREE daily newsletter.

MMEDF Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Psychedelic: MindMed announces dosing in Phase 3 Emerge study
See More Headlines

MMEDF Stock Analysis - Frequently Asked Questions

Mind Medicine (MindMed)'s stock was trading at $6.70 at the beginning of the year. Since then, MMEDF stock has decreased by 8.8% and is now trading at $6.11.
View the best growth stocks for 2025 here
.

Shares of MMEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MMEDF
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:MMEDF) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners